Global Potassium Heptadecanoate Market: Overview
The IUPAC name of potassium heptadecanoate is heptadecanoic acid. Potassium heptadecanoate has various synonyms such as heptadecanoic acid potassium salt (C17H33KO2). Heptadecanoic acid is a saturated fatty acid, and is also known as margaric acid (CH3(CH2)15COOH). Potassium heptadecanoate occurs as a component of fat and milk fat of ruminants. It does not occur in any natural vegetable or animal fat in much concentrations. Salts and esters of potassium heptadecanoate (heptadecanoic acid) are called heptadecanoates. Heptadecanoic acid (margaric acid) can also be used through the analysis of medium chain fatty acids from biomaterials such as seed oils and animal and plant oil.
Potassium heptadecanoates is primarily used in fatty acid from animal and plant oil or seed oil. Fatty acid is an unsaturated or saturated carboxylic acid, and is derived from triglycerides and phospholipids. It is said to be a vital source of fuel. As a source of fuel, several types of cell are use fatty acids. Fatty acids are also used in human nutrition, as deficit of fatty acids may lead to adverse biological effects in human body. Particularly brain, heart, and skeletal muscle are used fatty acids as a driving source. There are two types of fatty acids: those based on carbon bonds and length of free fatty acids. Fatty acids accounted for more than 40% of human fat, which is said to be unsaturated fatty acids. Fatty acids endure reactions similar to carboxylic acids such as esterification and acid base reactions.
The potassium heptadecanoate market has been segmented based on application and region. In terms of application, the market has been divided into pharmaceuticals, cosmetics, paints, varnishes, synthetic organic detergents, rubber compounding, insecticides, textile chemicals, plastic fabrication, pulp and paper products, synthetic rubber formulations, and others. Pharmaceuticals are used as inactive ingredients in the preparation of drugs and for lipid formulation. Complex lipids are used in the manufacture of soaps, cosmetics, emulsions, and fat liposomes. These are also used in personal hygiene products.
Rise in demand for personal and home care products in emerging economies in Latin America is expected to drive the potassium heptadecanoate market. Increase in demand for food and beverages in North America and Europe is also anticipated to boost market growth. On the other hand, occurrence of biological effects due to deficiency of fatty acids is estimated to hamper the potassium heptadecanoate market. Deficiency of fatty acid can lead to blood pressure problems, stroke, coronary artery disease, inflammation, etc.
Based on region, the potassium heptadecanoate market has been segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Asia Pacific is a key consumer and producer of potassium heptadecanoate. The market in the region is projected to expand significantly during the forecast period. Countries such as China, India, and Malaysia hold major share of the potassium heptadecanoate market in Asia Pacific. China accounts for more than 50% share of the market in Asia Pacific due to the high consumption of soaps and detergents in the country.
Europe also constitutes prominent share of consumption of potassium heptadecanoate. The market in the region is likely to expand at a moderate pace due to saturation, price fluctuation, and changes in trends. Demand for potassium heptadecanoate is moderate in North America; therefore, the market in the region is expected to expand at a sluggish pace during the forecast period due to the presence of well-developed and established industries. Brazil holds key share of the market in Latin America. Emerging economies such as India, China, Indonesia, and Brazil are expected to account for prominent share of the potassium heptadecanoate market during the forecast period. The market in Europe is likely to expand moderately, due to the high imports mostly in Turkey.
Key players operating in the potassium heptadecanoate market are Chengdu HappySyn Pharmaceutical Technology Co., Ltd., 360 Reagent, Shanghai Yolne Chemical Co., Ltd., BePharm Ltd, BIOTREND Chemikalien GmbH, American Radiolabeled Chemicals, Inc., Angene International Limited, Lead Biotech (Hangzhou) Co., Ltd., and Bide Pharmatech Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.